. Using 'omics' to define pathogenesis and biomarkers of Parkinson's disease. Expert Rev Neurother. 2010 Jun;10(6):925-42. PubMed.

Recommends

Please login to recommend the paper.

Comments

Make a Comment

To make a comment you must login or register.

Comments on this content

No Available Comments